Form 8-K - Current report:
SEC Accession No. 0001387131-20-005058
Filing Date
2020-05-21
Accepted
2020-05-21 07:05:45
Documents
6
Period of Report
2020-05-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_052120.htm 8-K 22408
2 POSTER PRESENTATION ex99-01.htm EX-99.01 1289
3 POSTER PRESENTATION ex99-02.htm EX-99.02 1295
4 PRESS RELEASE ex99-03.htm EX-99.03 14719
5 GRAPHIC ex9901_001.jpg GRAPHIC 987433
6 GRAPHIC ex9902_001.jpg GRAPHIC 3743431
  Complete submission text file 0001387131-20-005058.txt   6553513
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 20899982
SIC: 2834 Pharmaceutical Preparations